How to Stop Severe Nosebleeds with GT
At a Glance
To stop a Glanzmann Thrombasthenia nosebleed, sit upright, lean forward, and use prescribed tranexamic acid (TXA). Apply firm, continuous pressure with a nose clip for 15-20 minutes without stopping. Use a neck ice pack. Seek ER care if bleeding persists beyond 30 minutes.
In this answer
3 sections
Nosebleeds (epistaxis) are one of the most common and visible symptoms of Glanzmann Thrombasthenia (GT). Severe nosebleeds can be frightening and exhausting, but having a calm, step-by-step plan can help you stay in control. To manage a severe episode at home, lean slightly forward, apply firm and continuous pressure using a medical nose clip for 15 to 20 minutes, apply an ice pack to the back of your neck, and use prescribed antifibrinolytics like tranexamic acid (TXA) [1][2][3]. It is crucial not to tilt your head back, as this can cause blood to drain into your throat.
Step-by-Step Home Care for GT Nosebleeds
Because your platelets do not clump together properly to form clots, stopping a nosebleed with GT often requires more prolonged and targeted effort than it does for people without a bleeding disorder [4][1]. Follow these steps to manage the bleed:
- Position yourself correctly: Sit upright and lean slightly forward [5]. Leaning forward prevents blood from flowing down the back of your throat, which can cause nausea, vomiting, and choking.
- Administer prescribed medications: If your hematologist has prescribed topical antifibrinolytics, such as tranexamic acid (TXA) applied via specialized dissolvable packing or nasal tampons, insert this before applying pressure [3][5]. Only use specific packing products recommended by your doctor, as standard gauze or tissues can tear away the fragile clot when removed, causing severe re-bleeding. You may also need to take systemic (oral) TXA as directed by your care team [6].
- Apply firm, continuous pressure: Pinch the soft, fleshy part of your nose (just below the bony bridge) [5]. Use a medical-grade nose clip (available at pharmacies or medical supply stores) if you have one, as it provides consistent pressure without tiring your hand. You must maintain this pressure continuously for at least 15 to 20 minutes [1][2]. Do not let go to check if the bleeding has stopped before the time is up, as this breaks any fragile clot that has started to form.
- Use cold therapy: Apply an ice pack or a cold compress (wrapped in a cloth to prevent ice burns) to the back of your neck or over the bridge of your nose [7]. Cold temperatures help constrict the blood vessels, reducing blood flow to the area.
After the Bleeding Stops
Once you successfully stop the nosebleed, the clot that has formed is extremely fragile. To prevent the bleeding from restarting, you must protect this clot for several hours:
- Do not blow or pick your nose, and avoid forceful sneezing if possible.
- Do not bend over or lift heavy objects, as this increases blood pressure in your head.
- Avoid hot liquids and hot showers, because heat dilates blood vessels and can trigger a re-bleed.
When to Seek Emergency Care
While many nosebleeds can be managed at home, you must recognize when home care is no longer enough. You should seek emergency medical care if:
- The bleeding is severe, persistent, and does not stop after 20 to 30 minutes of continuous pressure and home treatments [7][2].
- You are swallowing large amounts of blood or feel dizzy, lightheaded, or weak, which can be signs of significant blood loss [1][8]. If you experience these symptoms, do not drive yourself. Have someone else drive you, or call 911.
- The nosebleed is refractory (resistant) to your usual first-line home management strategies [1].
When heading to the emergency room, bring your hematologist’s emergency contact information and your bleeding disorder travel/ER letter. Emergency staff are often unfamiliar with rare conditions like GT, and this documentation ensures they know that standard protocols may not be sufficient. In the hospital, doctors have access to advanced treatments, such as systemic interventions like platelet transfusions or recombinant activated factor VII (rFVIIa) to control the bleeding [9][10][4].
Common questions in this guide
How long should I apply pressure to stop a nosebleed with Glanzmann Thrombasthenia?
Should I tilt my head back during a severe nosebleed?
What medications help stop nosebleeds in Glanzmann Thrombasthenia?
What should I avoid after my nosebleed stops?
When should I go to the emergency room for a GT nosebleed?
Questions for Your Doctor
5 questions
- •What specific formulation of tranexamic acid (TXA) should I keep at home for nasal use, and exactly how should I apply it?
- •Can you recommend or prescribe a specific type of medical-grade nose clip to keep in my emergency kit?
- •At what point during a nosebleed should I take my oral antifibrinolytic medication versus relying only on topical treatments?
- •What specific dissolvable packing or nasal tampons are safe for me to use without risking re-bleeding when they are removed?
- •How does my specific history of isoantibodies affect the treatments I might receive in the ER if home care fails?
Questions for You
4 questions
- •How long do my nosebleeds typically last before I intervene, and have I been consistently applying pressure for the full 15-20 minutes?
- •Do I have all the necessary supplies (nose clips, ice packs, unexpired TXA, emergency letter) easily accessible in a specific place in my home?
- •Have I previously felt lightheaded or nauseous during a nosebleed because I leaned backward instead of forward?
- •What usually triggers my severe nosebleeds, and are there environmental factors I can manage better?
References
References (10)
- 1
Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders.
Fiore M, Giraudet JS, Alessi MC, et al.
Orphanet journal of rare diseases 2023; (18(1)):171 doi:10.1186/s13023-023-02787-2.
PMID: 37386449 - 2
Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report.
Hammami E, Fath L, Debry C, Desprez D
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2024; (35(2)):62-65 doi:10.1097/MBC.0000000000001272.
PMID: 38179703 - 3
Glanzmann Thrombasthenia: Use of the Soft Splint with Tranexamic Acid Paste to Reduce Spontaneous Oral Bleeding.
Bhavyaa R, Vignesh KC, Muthu MS, et al.
International journal of clinical pediatric dentistry 2021; (14(4)):580-585 doi:10.5005/jp-journals-10005-1973.
PMID: 34824518 - 4
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G, Zotz RB, d'Oiron R, et al.
Haematologica 2015; (100(8)):1031-7 doi:10.3324/haematol.2014.121475.
PMID: 26001793 - 5
Glanzmann thrombasthenia: Use of hemocoagulase (BotroClot) for arrest of bleeding during a primary tooth endodontic procedure.
Jairam LS, Kotha SB
Indian journal of dental research : official publication of Indian Society for Dental Research 2022; (33(2)):219-222 doi:10.4103/ijdr.ijdr_1191_21.
PMID: 36254965 - 6
Two case reports of Glanzmann thrombasthenia with intracranial hemorrhage and a review of the literature.
Almesedin GS, Alshmaily HO, Alshammari KA, Albalawi RS
Surgical neurology international 2023; (14()):448 doi:10.25259/SNI_680_2023.
PMID: 38213436 - 7
Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia.
Michali M, Basiari L, Komnos I, et al.
Maedica 2023; (18(2)):363-367 doi:10.26574/maedica.2023.18.2.363.
PMID: 37588843 - 8
Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.
Lee SM, Kim KN, Kim SY
Acta haematologica 2019; (142(4)):244-248 doi:10.1159/000499362.
PMID: 31085914 - 9
Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review.
Saultier P, Grino M, Falaise C, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(1)):7-15 doi:10.1111/hae.15130.
PMID: 39604156 - 10
Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports.
Almatar E, Alsharidah S, Hashem OA
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2025; (36(6)):293-295 doi:10.1097/MBC.0000000000001380.
PMID: 40673721
This page provides educational information on managing nosebleeds with Glanzmann Thrombasthenia. Always follow your hematologist's personalized emergency bleeding plan and seek immediate care if you experience significant blood loss.
Get notified when new evidence is published on Glanzmann Thrombasthenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.